Market Cap 42.96B
Revenue (ttm) 364.21B
Net Income (ttm) 8.29B
EPS (ttm) N/A
PE Ratio 7.06
Forward PE 4.63
Profit Margin 2.27%
Debt to Equity Ratio 0.00
Volume 346,768
Avg Vol 375,890
Day's Range N/A - N/A
Shares Out 5.01B
Stochastic %K 27%
Beta 1.06
Analysts Sell
Price Target $10.68

Company Profile

Volkswagen AG manufactures automobiles and commercial vehicles in Europe, Germany, North America, South America, the Asia-Pacific, and internationally. It operates through three segments: Passenger Cars and Light Commercial Vehicles; Commercial Vehicles; and Financial Services. The Passenger Cars and Light Commercial Vehicles segment develops vehicles, engines and motors, vehicle software, and vehicle batteries; produces and sells passenger cars and light commercial vehicles, and the parts. This...

Industry: Auto Manufacturers
Sector: Consumer Cyclical
Phone: 49 5361 9 0
Fax: 49 5361 9 28282
Address:
Berliner Ring 2, Wolfsburg, Germany
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 7:52 PM
$GME $MRNA $SLS $VWAGY Dr. Webber Developed $MRNA Vaccine technology we are all celebrating today. Dr. Webber on $SLS "Through my years of working in cancer immunotherapy, I have witnessed great advances in the field, and I believe SELLAS is on the verge of such an advance. I have been impressed with the significant potential of the Company's lead product, galinpepimut-s, to successfully treat hematological and solid malignancies through a unique approach of peptide-based immunization against the WT1 oncoprotein," stated Dr. Weber "I am excited to join the other scientists on the Company's SAB and offer the insights that I have in the area of oncoimmunology research and development."!!! 🤐 🎤 ✌️🙏❤️‍🩹
1 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 7:47 PM
$GME $MRNA $SLS $VWAGY Shorts running Out of time to cover or 🔥 ✌️🙏❤️‍🩹
1 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 7:34 PM
$GME $MRNA $SLS $VWAGY $SLS Shorts will have margin calls starting after hours today and will face complete liquidation after GPS Regal Pivotal Registrational Phase 3 data due Any Time Now. ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 7:13 PM
$GME $MRNA $SLS $VWAGY Part 2. Moderna shorts reportedly suffer $5B loss after stock's sudden rise Aug 19, 2026, 1:20 PM ET | Moderna, Inc. (MRNA) Stock MRK | By: Dulan Lokuwithana, SA News Editor. 👇 ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 7:04 PM
$GME $MRNA $SLS $VWAGY Plus Triple the shares short compared to $MRNA. Plus Sellas GPS CURATIVE Platform Is targeting 20+ WT1 cancers. The real breakthrough is dual MHC Class I and Class II activation. Multivalency also ensures the cancer can't run. Together, they create a self-sustaining, polyclonal, living defense system inside the patient, one that hunts WT1-expressing cells for the rest of their life. And the GPS responders? They aren't likely just surviving. They are functionally cured. Not managed. Not in fragile remission. CURED. With infinite dosing their T cells are still patrolling YEARS later. No cytokine storms. No need for a donor search. An off-the-shelf injection that reprograms immunity itself. ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 6:58 PM
$GME $MRNA $SLS $VWAGY Greg, $SLS has half the float of $MRNA so double the impact after Top line data= $240.00+ ✌️🙏❤️‍🩹
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Aug. 19 at 6:50 PM
$GME $MRNA $SLS $VWAGY SLS Shorts Continue to Cover - as we Await the Imminent Phase 3 Registrational Results. 27% of the Float - is Still Massively Squeezy
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 6:41 PM
$GME $MRNA $SLS $VWAGY 30% of SLS float is short going in to the biggest Catalyst in Sellas Corporate history GPS Regal Pivotal Registrational Phase 3 Commercialization ready Cancer platform = $240.00++ ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 6:37 PM
$GME $MRNA $SLS $VWAGY In October 2008, Volkswagen shares briefly surged over 400% in two days, jumping from roughly €210 to over €1,000. This brief spike made the German automaker the most valuable company in the world and cost short-selling hedge funds an estimated $30 billion. $SLS is in the same position right now because market is pricing 0% chance of success while the CEO Dr. Stergiou is saying Curative. KOL showing extremely bullish in success. GPS Ad Infinitum Dosage = CURE for Cancer. 👇 ✌️🙏❤️‍🩹
1 · Reply
BMakingMoney
BMakingMoney Aug. 18 at 11:29 AM
$DJT get ready for even HIGHER taxes and inflation and the death of your auto industry. $TM $STLA $VWAGY $F
1 · Reply
Latest News on VWAGY
No data available.
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 7:52 PM
$GME $MRNA $SLS $VWAGY Dr. Webber Developed $MRNA Vaccine technology we are all celebrating today. Dr. Webber on $SLS "Through my years of working in cancer immunotherapy, I have witnessed great advances in the field, and I believe SELLAS is on the verge of such an advance. I have been impressed with the significant potential of the Company's lead product, galinpepimut-s, to successfully treat hematological and solid malignancies through a unique approach of peptide-based immunization against the WT1 oncoprotein," stated Dr. Weber "I am excited to join the other scientists on the Company's SAB and offer the insights that I have in the area of oncoimmunology research and development."!!! 🤐 🎤 ✌️🙏❤️‍🩹
1 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 7:47 PM
$GME $MRNA $SLS $VWAGY Shorts running Out of time to cover or 🔥 ✌️🙏❤️‍🩹
1 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 7:34 PM
$GME $MRNA $SLS $VWAGY $SLS Shorts will have margin calls starting after hours today and will face complete liquidation after GPS Regal Pivotal Registrational Phase 3 data due Any Time Now. ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 7:13 PM
$GME $MRNA $SLS $VWAGY Part 2. Moderna shorts reportedly suffer $5B loss after stock's sudden rise Aug 19, 2026, 1:20 PM ET | Moderna, Inc. (MRNA) Stock MRK | By: Dulan Lokuwithana, SA News Editor. 👇 ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 7:04 PM
$GME $MRNA $SLS $VWAGY Plus Triple the shares short compared to $MRNA. Plus Sellas GPS CURATIVE Platform Is targeting 20+ WT1 cancers. The real breakthrough is dual MHC Class I and Class II activation. Multivalency also ensures the cancer can't run. Together, they create a self-sustaining, polyclonal, living defense system inside the patient, one that hunts WT1-expressing cells for the rest of their life. And the GPS responders? They aren't likely just surviving. They are functionally cured. Not managed. Not in fragile remission. CURED. With infinite dosing their T cells are still patrolling YEARS later. No cytokine storms. No need for a donor search. An off-the-shelf injection that reprograms immunity itself. ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 6:58 PM
$GME $MRNA $SLS $VWAGY Greg, $SLS has half the float of $MRNA so double the impact after Top line data= $240.00+ ✌️🙏❤️‍🩹
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Aug. 19 at 6:50 PM
$GME $MRNA $SLS $VWAGY SLS Shorts Continue to Cover - as we Await the Imminent Phase 3 Registrational Results. 27% of the Float - is Still Massively Squeezy
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 6:41 PM
$GME $MRNA $SLS $VWAGY 30% of SLS float is short going in to the biggest Catalyst in Sellas Corporate history GPS Regal Pivotal Registrational Phase 3 Commercialization ready Cancer platform = $240.00++ ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 19 at 6:37 PM
$GME $MRNA $SLS $VWAGY In October 2008, Volkswagen shares briefly surged over 400% in two days, jumping from roughly €210 to over €1,000. This brief spike made the German automaker the most valuable company in the world and cost short-selling hedge funds an estimated $30 billion. $SLS is in the same position right now because market is pricing 0% chance of success while the CEO Dr. Stergiou is saying Curative. KOL showing extremely bullish in success. GPS Ad Infinitum Dosage = CURE for Cancer. 👇 ✌️🙏❤️‍🩹
1 · Reply
BMakingMoney
BMakingMoney Aug. 18 at 11:29 AM
$DJT get ready for even HIGHER taxes and inflation and the death of your auto industry. $TM $STLA $VWAGY $F
1 · Reply
ResilientI
ResilientI Aug. 13 at 3:20 PM
$VWAGY $XPEV this means additional income for Xpeng “doing almost nothing”, and indirectly for VW too holding roughly 5% of Xpeng shares.
0 · Reply
BMakingMoney
BMakingMoney Aug. 12 at 2:49 PM
$DJT $F nobody is buying the new Fathom EV truck. Without Auto Partners in Canada. CUSMA is bound to fail with Rump “negotiating”. China will eat the US Auto market alive! $TSLA $STLA $VWAGY
1 · Reply
EV_Report
EV_Report Aug. 12 at 2:30 PM
Porsche Quits VW Emissions Pool as EV Sales Slump, Turns to China’s XPeng $VWAGY $XPEV https://eletric-vehicles.com/xpeng/porsche-quits-vw-emissions-pool-as-ev-sales-slump-turns-to-chinas-xpeng/
0 · Reply
snowPOW
snowPOW Aug. 10 at 4:35 PM
$BB India is the world's third largest car market. The first is China, the second is the USA BlackBerry is in all three. $F $VWAGY $STLA
0 · Reply
x2073
x2073 Aug. 8 at 5:32 PM
$VWAGY Hoping for the best. Many like this out there. Nissan Stelantis Porsche Daimler etc.
0 · Reply
VirusBear
VirusBear Aug. 5 at 4:32 PM
$RIVN $VWAGY This partnership will only grow, imo. Very beneficial to Rivian once they start production. Proximity between the two new factories doesn't hurt either... https://www.torquenews.com/1/i-visited-scout-motors-construction-site-south-carolina-and-scale-ev-factory-starting-become-real
0 · Reply
Nosecandy_Bear
Nosecandy_Bear Aug. 5 at 12:47 AM
$RIVN has a MC of over 22B with annual revenue of only 5B. Meanwhile $F has a MC of 55B with annual revenue of over 180B. The mechanics of the auto and EV sectors are whack. You can talk software and hardware stacks all you want, but $VWAGY is a dying conglomerate auto company.
0 · Reply
WeTheMarket
WeTheMarket Aug. 4 at 2:43 PM
$INVZ $NVDA $MBLY $BMWYY $VWAGY Insights from Google Gemini (AI): "Innoviz's announcement of a development program with a top-10 global OEM for a highway perception stack is a key structural shift from pure hardware supplier to full-stack "Physical AI" provider. By pairing InnovizTwo hardware with their native Point Cloud Plus software on NVIDIA's compute platform, Innoviz expands beyond hardware ASPs toward higher-margin software licensing and deeper system stickiness. While this is an R&D/validation phase rather than a finalized series production award, co-developing pixel-level hazard detection (solving the "unknown object" blindspot of camera-only setups) directly with a major OEM lowers integration friction and positions Innoviz as a front-runner for future L2+/L3 platform standardizations. Key metrics to monitor: transition from evaluation to production design wins and software margin mix in future filings."
0 · Reply
AFONSOEV_
AFONSOEV_ Jul. 30 at 8:33 PM
Rivian Says Volkswagen JV Drove $308 Million of Its Record Software Quarter — EV $RIVN $VWAGY https://eletric-vehicles.com/rivian/rivian-says-volkswagen-jv-drove-308-million-of-its-record-software-quarter
0 · Reply
x2073
x2073 Jul. 29 at 8:30 PM
Ev$MU I like multi year low stocks with good reason to be so. Recently $CHTR $CMCSA $VWAGY $STLA others...
0 · Reply
EV_Report
EV_Report Jul. 29 at 4:28 PM
Porsche Keeps Its 24-26% Annual EV Target Despite Slower First Half $VWAGY https://eletric-vehicles.com/vw-group/porsche/porsche-keeps-its-24-26-annual-ev-target-despite-slower-first-half/
0 · Reply
Warpig83
Warpig83 Jul. 29 at 3:11 PM
$VWAGY this is beat down so bad aggravated assault charges should be filed
0 · Reply